1Find ME.Treatment of the critically ill patient with myasthenia gravis.In:Ropper AH,ed.Neurological and neurosurgical intensive care[M].3rd ed.NY:Raven press,1993:351-362.
2Keesey JC.Clinical evaluation and management of myasthenia gravis[J].Muscle Nerve,2004,29(4):484-505.
4Kupersmith MJ,Latkany R,Homel P.Devdopmem of generalized disease at 2 years in patients with ocular myasthenia gcavis[J].Arch Neurol,2003,60(2):243-248.
5Sommier FE,Trojaborg W.Neurophysioiogical evaluation in myasthenia gravis.A comprehensive study of a complete patient poulaion[J].Electroencephalogrphy Clin Neurophysiol,1993,89(2):73-87.
2[10]Quality Assurance Committee,AAEM.Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome:summary statement[J].Muscle Nerve,2001,24:1236.
3[1]Keesey JC.Clinical evaluation and management of myasthenia gravis[J].Muscle Nerve,2004,29:484.
4[2]Mantegazza R,Beghi E,Pareyson D,et al.A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy[J].J Neurol,1990,237:339.
5[3]Kupersmith MJ,Latkany R,Homel P.Development of generalized disease at 2 years in patients with ocular myasthenia gravis[J].Arch Neurol,2003,60:243.
6[5]Borohn RJ,McIntire D,Herbelin L,et al.Reliability test of the quantitative myasthenia gravis score[J].Ann NY Acad Sci,1998,841:769.
